Protein phosphatase activity in human keratinocytes cultured from normal epidermis and epidermis from patients with harlequin ichthyosis

British Journal of Dermatology

Volumn 137, Issue 6, 1997, Pages 874-882

  Kam, E ^a   Nirunsuksiri, W ^a   Hager, B ^a   Fleckman, P ^a   Dale, B A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME KINETICS; EPIDERMIS; HUMAN; HUMAN CELL; ICHTHYOSIS; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

EID: 0031434590     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01546.x     Document Type: Article

References (61)

1. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 1989; 58: 453-508.
2. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995; 80: 225-36.
3. Wera S, Hemmings BA. Serine/threonine protein phosphatases. Biochem J 1995; 311: 17-29.
4. Yuspa SH, Ben T, Hennings H. The induction of epidermal transglutaminase and terminal differentiation by tumor promoters in cultured epidermal cells. Carcinogenesis 1983; 4: 1413-18.
5. Dlugosz AA, Yuspa SH. Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C. J Cell Biol 1993; 120: 217-25.
6. Denning MF, Dlugosz AA, Williams EK et al. Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium. Cell Growth Differ 1995; 6: 149-57.
7. Szallasi Z, Kosa K, Smith CB et al. Differential regulation by anti tumor promoting 12 deoxyphorbol 13 phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytes. Mol Pharmacol 1995; 47: 258-65.
8. Chakravarthy BR, Isaacs RJ, Morley P et al. Stimulation of protein kinase C during Ca(2+) induced keratinocyte differentiation. Selective blockade of MARCKS phosphorylation by calmodulin. J Biol Chem 1995; 270: 1362-8.
9. Dlugosz AA, Mischak H, Mushinski JF, Yuspa SH. Transcripts encoding protein kinase C alpha, delta, epsilon, zeta, and eta are expressed in basal and differentiating mouse keratinocytes in vitro and exhibit quantitative changes in neoplastic cells. Mol Carcinog 1992; 5: 286-92.
10. Koizumi H, Kohno Y, Osada S et al. Differentiation associated localization of nPKC eta, a Ca(++) independent protein kinase C, in normal human skin and skin diseases. J Invest Dermatol 1993; 101: 858-63.
11. Castagna M, Takai Y, Kaibuchi K et al. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumour-promoting phorbol esters. J Biol Chem 1982; 257: 7847-51.
12. Suganuma M, Fujiki H, Suguri H et al. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 1988; 85: 1768-71.
13. Suganuma M, Fujiki H, Furuya S-H et al. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD 1 mouse skin. Cancer Res 1990; 50: 3521-5.
14. Haugen-Scofield J, Resing KA, Dale BA. Characterization of an epidermal phosphatase specific for filaggrin phosphorylated by casein kinase II. J Invest Dermatol 1988; 91: 553-9.
15. Kam E, Resing KA, Lim SK, Dale BA. Identification of rat epidermal profilaggrin phosphatase as a member of the protein phosphatase 2A family. J Cell Sci 1993; 106: 219-26.
16. Dale BA, Presland RB, Fleckman P et al. Phenotypic expression and processing of filaggrin in epidermal differentiation. In: Molecular Biology of the Skin (Darmon M, Blumenberg M, eds). Orlando: Academic Press Inc., 1992; 79-106.
17. Kasahara K, Kartasova T, Ren XQ et al. Hyperphosphorylation of keratins by treatment with okadaic acid of BALB/MK 2 mouse keratinocytes. J Biol Chem 1993; 268: 23531-7.
18. Yatsunami J, Komori A, Ohta T et al. Hyperphosphorylation of cytokeratins by okadaic acid class tumor promoters in primary human keratinocytes. Cancer Res 1993; 53: 992-6.
19. Serres M, Grangeasse C, Haftek M et al. Hyperphosphorylation of beta-catenin on serine-threonine residues and loss of cell-cell contacts induced by calyculin A and okadaic acid in human epidermal cells. Exp Cell Res 1997; 231: 163-72.
20. Kumar M, Spandau DF. The effect of phosphorylation on the antigenic reactivity of p53 in cultured human keratinocytes. Biochem Biophys Res Commun 1995; 214: 744-53.
21. Peng J, Bowden GT, Domann FE. Activation of AP-1 by okadaic acid in mouse keratinocytes associated with hyperphosphorylation of c-jun. Mol Carcinog 1997; 18: 37-43.
22. Roberge M, Tudan C, Hung SM et al. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A. Cancer Res 1994; 54: 6115-21.
23. Lee TH, Turck C, Kirschner MW. Inhibition of cdc2 activation by INH/PP2A. Mol Biol Cell 1994; 5: 323-38.
24. Wera S, Fernandez A, Lamb NJ et al. Deregulation of translational control of the 65 kDa regulatory subunit (PR65alpha) of protein phosphatase 2A leads to multinucleated cells. J Biol Chem 1995; 270: 21374-81.
25. Garcia I, Pipaon C, Alemany S, Perez C-A. Induction of NGFI B gene expression during T cell activation. Role of protein phosphatases. J Immunol 1994; 153: 3417-25.
26. Haby C, Aunis D, Zwiller J. Okadaic acid induces activator protein 1 activity and immediate early gene transcription in rat pheochromocytoma cells. Mechanism of action. Biochem Pharmacol 1994; 48: 819-25.
27. Sontag E, Nunbhakdi C-V, Bloom GS, Mumby MC. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol 1995; 128: 1131-44.
28. Dale BA, Kam E. Harlequin ichthyosis. Variability in expression and hypothesis for disease mechanism. Arch Dermatol 1993; 129: 1471-7.
29. Williams ML. Ichthyosis: mechanisms of disease. Pediatr Dermatol 1992; 9: 365-8.
30. Akiyama M, Yoneda K, Kim SY et al. Cornified cell envelope proteins and keratins are normally distributed in harlequin ichthyosis. J Cutan Pathol 1996; 23: 571-5.
31. Akiyama M, Kim SY, Yoneda K, Shimizu H. Expression of transglutaminase 1 (transglutaminase K) in harlequin ichthyosis. Arch Dermatol Res 1997; 289: 116-19.
32. Dale BA, Holbrook KA, Fleckman P et al. Heterogeneity in harlequin ichthyosis, an inborn error of epidermal keratinization: variable morphology and structural protein expression and a defect in lamellar granules. J Invest Dermatol 1990; 94: 6-18.
33. Milner ME, O'Guin WM, Holbrook KA, Dale BA. Abnormal lamellar granules in harlequin ichthyosis. J Invest Dermatol 1992; 99: 824-9.
34. Hashimoto K, Khan S. Harlequin fetus with abnormal lamellar granules and giant mitochondria. J Cutan Pathol 1992; 19: 247-52.
35. Haftek M, Cambazard F, Dhouailly D et al. A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma. Br J Dermatol 1996; 135: 448-53.
36. Cohen P, Klumpp S, Schelling DL. An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett 1989; 250: 596-600.
37. Sim AT, Mudge LM. Protein phosphatase activity in cyanobacteria: consequences for microcystin toxicity analysis. Toxicon 1993; 31: 1179-86.
38. Eichner R, Bonitz P, Sun T-T. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J Cell Biol 1984; 98: 1388-96.
39. Nirunsuksiri W, Presland RB, Brumbaugh SG et al. Decreased profilaggrin expression in ichthyosis vulgaris is a result of selectively impaired posttranscriptional control. J Biol Chem 1995; 270: 871-6.
40. Khew G-Y, Mayer RE, Maurer F et al. Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. Biochemistry 1991; 30: 89-97. [Erratum appears in Biochemistry 1991; 30: 5328].
41. Fleckman P, Haydock P, Blomquist C, Dale BA. Profilaggrin and the 67 kDa keratin are coordinately expressed in cultured human epidermal keratinocytes. J Cell Biol 1984; 99: 315A.
42. Hohl D, Lichti U, Breitkreutz D et al. Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid. J Invest Dermatol 1991; 96: 414-18.
43. Fleckman P, Dale BA, Holbrook KA. Profilaggrin, a high molecular weight precursor of filaggrin in human epidermis and cultured keratinocytes. J Invest Dermatol 1985; 85: 507-12.
44. Cohen P. The role of protein phosphorylation in the hormonal control of enzyme activity. Eur J Biochem 1985; 151: 439-48.
45. Tawara I, Nishikawa M, Morita K et al. Down regulation by retinoic acid of the catalytic subunit of protein phosphatase type 2A during granulocytic differentiation of HL 60 cells. FEBS Lett 1993; 321: 224-8.
46. 3 induced monocytic differentiation of HL 60 cells. Cancer Res 1995; 55: 774-80.
47. Imaoka T, Imazu M, Usui H et al. Resolution and reassociation of three distinct components from heart phosphorprotein phosphatase. J Biol Chem 1983; 258: 1526-35.
48. Chen SC, Kramer G, Hardesty B. Isolation and partial characterization of an Mr 60,000 subunit of a type 2A phosphatase from rabbit reticulocytes. J Biol Chem 1989; 264: 7267-75.
49. Hendrix P, Mayer J-RE, Cron P et al. Structure and expression of a 72 kDa regulatory subunit of protein phosphatase 2A. Evidence for different size forms produced by alternative splicing. J Biol Chem 1993; 268: 15267-76.
50. Mumby MC, Russell KL, Garrard LJ, Green DD. Cardiac contractile protein phosphatases. Purification of two enzyme forms and their characterization with subunit specific antibodies. J Biol Chem 1987; 262: 6257-65.
51. Kamibayashi C, Estes R, Slaughter C, Mumby MC. Subunit interactions control protein phosphatase 2A. Effects of limited proteolysis, N ethylmaleimide, and heparin on the interaction of the B subunit. J Biol Chem 1991; 266: 13251-60.
52. Kamibayashi C, Estes R, Lickteig RL et al. Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. J Biol Chem 1994; 269: 20139-48.
53. Mayer-Jaekel RE, Baumgartner S, Bilbe G et al. Molecular cloning and developmental expression of the catalytic and 65 kDa regulatory subunits of protein phosphatase 2A in Drosophila. Mol Biol Cell 1992; 3: 287-98.
54. Mayer-Jaekel RE, Ohkura H, Ferrigno P et al. Drosophila mutants in the 55 kDa regulatory subunit of protein phosphatase 2A show strongly reduced ability to dephosphorylate substrates of p34cdc2. J Cell Sci 1994; 107: 2609-16.
55. McCright B, Virshup DM. Identification of a new family of protein phosphatase 2A regulatory subunits. J Biol Chem 1995; 270: 26123-8.
56. Chen J, Martin BL, Brautigan DL. Regulation of protein serine threonine phosphatase type 2A by tyrosine phosphorylation. Science 1992; 257: 1261-4.
57. Guo H, Damuni Z. Autophosphorylation activated protein kinase phosphorylates and inactivates protein phosphatase 2A. Proc Natl Acad Sci USA 1993; 90: 2500-4.
58. Favre B, Zolnierowicz S, Turowski P, Hemmings BA. The catalytic subunit of protein phosphatase 2A is carboxyl methylated in vivo. J Biol Chem 1994; 269: 16311-17.
59. Xie H, Clarke S. Protein phosphatase 2A is reversibly modified by methyl esterification at its C terminal leucine residue in bovine brain. J Biol Chem 1994; 269: 1981-4.
60. Turowski P, Fernandez A, Favre B et al. Differential methylation and altered conformation of cytoplasmic and nuclear forms of protein phosphatase 2A during cell cycle progression. J Cell Biol 1995; 129: 397-410.
61. Lonsdale-Eccles JD, Teller DC, Dale BA. Characterization of a phosphorylated form of the intermediate filament aggregating protein, filaggrin. Biochemistry 1982; 21: 5940-8.